Back Home

Maximizing Immunoassay Performance

Maximizing Immunoassay Performance

  • HOME
  • ABOUT US
    • Founders
    • Why InfYnity
    • Who we are
    • What we do
  • OFFER
    • Biomaterial Products
    • Biomaterial Design
    • Immunoassay RUO products
    • Immunoassay Development Services
    • Multiplex Services
  • CONTACT US
    • Careers
  • Pipeline
  • Partners
Home » 2019 » December » 04

News

  • Lancet Infectious Disease publication on an innovative multiplex test for forecasting parasitological cure in Chagas patients
  • InfYnity Multiplex ELISA Platform: Reliable & Highly Reproducible
  • MEDICA (November 18-21, 2019)
  • HERVS & Disease (November 5-6, 2019)
  • Chagas Disease Monitoring: Time for analysis of serological patterns
  • NIH Award to develop a Test-of-Cure for Chagas disease
  • Stars of Science – Session 10 (2018)
  • Chagas Platform Meeting (November 14-15, 2018)
  • MEDICA (November 12-15, 2018)
  • Biotuesday (September 4, 2018)

Daily Archives: December 4, 2019


InfYnity Biomarkers is glad to announce that it has developed within a scientific collaboration with Janssen, a novel Multiplex ELISA assay for Onchocerciasis. The assay has been tested on almost 500 patient samples using three different production lots to assess reproducibility. The Multiplex platform was shown to be highly reproducible […]

InfYnity Multiplex ELISA Platform: Reliable & Highly Reproducible

4 Dec, 2019  in Biotechnology by admin


INFYNITY BIOMARKERS

78-80 rue du Bourbonnais
69009 Lyon – France

Tel: +33 4 72 76 20 29
Fax: +33 9 81 38 17 15
Email: info@infynity-biomarkers.com

Map: https://map.what3words.com/portique.retrouvons.sportif

Mentions Légales

 

· © 2022 infYnity-biomarkers ·

Web Design MymensinghPremium WordPress ThemesWeb Development